AI assistant
SURMODICS INC — Director's Dealing 2019
Oct 3, 2019
32845_dirs_2019-10-03_e8abe6b8-3bcb-449f-a32e-2fc5c943f2aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-10-01
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-01 | Common Stock | S | 4700 | $45.4585 | Disposed | 132953 | Direct |
| 2019-10-01 | Common Stock | S | 300 | $46.1417 | Disposed | 132653 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019.
F2: Reflects the weighted average price of 4,700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2019 with sale prices ranging from $45.01 to $45.945 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects the weighted average price of 300 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2019 with sale prices ranging from $46.06 to $46.305 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.